0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Reviews |

Acquired C1 Esterase Inhibitor Deficiency

Svetomir N. Markovic, MD, PhD; David J. Inwards, MD; Evangelos A. Frigas, MD; and Robert P. Phyliky, MD
[+] Article and Author Information

From Mayo Clinic, Rochester, Minnesota.


Grant Support: From the Mayo Foundation.

Requests for Reprints: Svetomir N. Markovic, MD, PhD, Division of Hematology, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester MN, 55901. For reprint orders in quantities exceeding 100, please contact the Reprints Coordinator; phone, 215-351-2657; e-mail, reprints@mail.acponline.org.

Current Author Addresses: Drs. Markovic, Inwards, and Phyliky: Division of Hematology, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55901.

Dr. Frigas: Division of Allergy and Outpatient Infectious Diseases, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55901.


Ann Intern Med. 2000;132(2):144-150. doi:10.7326/0003-4819-132-2-200001180-00009
Text Size: A A A

The complement system was first described in the late 19th century as the property of fresh serum to cause in vitro cell death after agglutination. It represents the oldest identified component of the immune system. The complement system consists of a series of about 20 different serum proteins that are part of the body's first-line, innate immune defenses (Figure 1). As such, the complement system is a triggered cascade of highly amplified proteolytic reactions ultimately leading to enhanced adherence of offending microorganisms, stimulation of more effective inflammation and phagocytosis, and direct lysis of the offending cells. The complement system is divided into two pathways on the basis of the trigger of the complement cascade. The classic pathway is activated when C1 binds to the Fc fragment of IgM or IgG in immune complexes. The inactive C1 molecule has three subunits—C1q, C1r, and C1s—that are held together by ionic calcium. The C1q component binds to immunoglobulin in the immune complex. With the binding of C1q, C1r undergoes enzymatic cleavage of its two subunits, exposing active proteolytic sites. The activated proteolytic site on C1r cleaves the C1s peptide, exposing its active enzymatic site. In turn, activated C1s acts as a protease for both C4 and C2. With the activation of C4 and C2 into C4b,2a complex, the C3 convertase enzyme is created (Figure 1). The activation of the alternate complement pathway is somewhat less clear. It involves the activation of C3 by a C3-convertase complex consisting of C3b,Bb. Under normal circumstances, low levels of turnover of C3 to C3b take place. During inflammation, low levels of C3b bind factor B, which then undergoes enzymatic cleavage by factor D to generate C3b, Bb. This in turn acts as a potent C3 convertase, amplifying the complement cascade. Therefore, successful generation of a C3-convertase enzyme complex is central to the process of complement activation by either pathway.

First Page Preview

View Large
First page PDF preview

Figures

Grahic Jump Location
Figure 1.
Classic diagram of the complement cascade.

MAC = membrane attack complex.

Grahic Jump Location
Grahic Jump Location
Figure 2.
The mechanism of angioedema caused by C1 esterase deficiency.

The central role of C1 esterase inhibitor as a downregulator of C1 and plasmin activity, both of which play a role in angioedema, is shown. * Activated C1.

Grahic Jump Location
Grahic Jump Location
Figure 3.
Proposed work-up flow sheet for patients with a clinical history of angioedema.
Grahic Jump Location

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
A case of transient acquired C1 inhibitor deficiency. Ann Allergy Asthma Immunol 2014;113(1):116-7.
Recurrent angio-oedema--three cases of C1 inhibitor deficiency. J Assoc Physicians India 2013;61(12):927-30.
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)